Sun Pharmaceutical Industries Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1808.85

-14.45 (-0.79%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1808.85

-14.45 (-0.79%)
16:02 Dec 20

Quality

95/100
High Financial Strength

Valuation

31/100
Mid Valuation

Technical

56/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	33498.14	38654.49	43885.68	48496.85	50307.74
Operating Expenses +	25006.77	28256.77	32238.89	35473.72	36249.18
Raw Material	9328.3	10459.15	11349.07	10370.48	10234.02
Increase Decrease in Cost	-638.22	-107.61	-686.91	292.13	252.96
Other Manufacturing Expense	0	557.81	561.32	630.26	0
Employee Cost	6862.23	7300.83	8296.03	9429.06	9594.98
Miscellaneous Expenses	15804.8	16866.65	19862.38	21684.09	16167.22
Operating Profit	8491.37	10397.72	11646.79	13023.13	14058.56
Other Income	835.52	921.51	634.52	1354.19	1742.69
Depreciation	2079.95	2143.74	2529.43	2556.64	2553.54
Interest	141.43	127.35	172	238.47	239.01
Profit before tax and exceptio..	7105.51	9048.14	9579.88	11582.21	13008.7
Exceptional Items	-4306.14	-4566.82	-171.45	-494.32	-171.45
PBT	2799.37	4481.32	9408.43	11087.89	13180.15
Provision for Taxation	514.69	1075.5	847.59	1439.45	1700.71
Net Profit	2284.68	3405.82	8560.84	9648.44	11136.54
NET Profit after MI	2903.82	3272.73	8473.58	9576.38	11054.11
EPS	12.1	13.6	35.3	39.9	46.1
Operating Profit Margin (%)	25.35	26.9	26.54	26.85	27.95
Net Profit Margin (%)	8.67	8.47	19.31	19.75	21.97

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	54.50	54.50	54.50	54.50	54.50
FII	18.00	17.20	17.70	17.10	16.80
MF	12.10	12.80	12.20	12.90	13.10
Public	8.90	9.00	9.00	8.90	9.00
Others	0.00	0.00	0.00	0.00	0.10
Others	6.50	6.50	6.60	6.60	6.50